PT Biometrik Riset Indonesia commemorated the 60th National Health Day by participating as a speaker in the Health Innovation Festival Talk Show organized by the Ministry of Health

Writer and Editor : Canaya Vania Rehansha

Jakarta, November 11, 2024 – In celebration of National Health Day (HKN) as a milestone of six decades of achievements in the health sector, PT Biometrik Riset Indonesia was invited to speak at the spectacular event organized by the Ministry of Health Republic Indonesia. The event, titled the Health Innovation Festival - Hai Fest 2024, was successfully held from November 7-9, 2024 at Jakarta Convention Centre (JCC) Hall B.

In addition to offering various engaging and beneficial activities, Hai Fest 2024 served as a platform to introduce the latest innovations in healthcare to the public. Aligned with these innovations, PT Biometrik Riset Indonesia presented a talk show titled The Role of Bioequivalence Testing in Ensuring Drug Quality, Efficacy, and Safety: What and How? delivered by Mrs. Effi Setiawati, an Expert in Bioequivalence (BE) Testing and Chair of the Indonesian BE Testing Centres Association. Ensuring drug quality, efficacy, and safety is a priority principle for PT Biometrik Riset Indonesia, not only enhancing public trust in generic products but also ensuring access to more affordable treatments.

The second presentation was delivered by Mr. Andi Darmawan, Technical Manager of PT Biometrik Riset Indonesia, covering the topic The Application of GCP and GLP in Ensuring Reliable Bioequivalence Test Results. GCP ensures that clinical data is obtained ethically and consistently, while GLP guarantees accurate and reproducible analytical laboratory data.

Moderated by Ms. Oktaviani Utami Dewi, the discussion proceeded smoothly and engaged the audience with enthusiasm. This enthusiasm was evident from the variety of questions asked during the discussion and Q&A session. With the conclusion of the HKN talk show session, PT Biometrik Riset Indonesia hopes that the public will gain a deeper understanding of the vital role of Bioequivalence Testing in ensuring the safety of the medications they consume.